Effects of vasoactive intestinal polypeptide infusions on renal function in @entity1 with XXXX .

@entity1 @entity3549 @entity1575 @entity409 @entity1372 @entity460 @entity972 @entity916
1. The effect of intravenous vasoactive intestinal peptide ( @entity3549 , 6 pmol/kg per min) on renal function in six @entity1 with @entity1575 was examined. 2. @entity3549 caused generalized vasodilation and increased plasma @entity916 activity, but diminished the glomerular filtration rate by about one third. 3. The excretion of water, @entity1372 , @entity972 and @entity460 also fell significantly. 4. These results differ from our findings in normal @entity1 in whom @entity3549 diminished water and electrolyte secretion largely by increasing tubular reabsorption. 5. It is concluded that the elevated @entity3549 levels present in @entity1 with severe @entity409 may affect renal function, but that the presence of @entity409 may affect renal responses to @entity3549 .
